19 ottobre 2016 Radioterapia

First IBA proton therapy center in Russia

IBA, the world’s leading provider of proton therapy solutions for the treatment of cancer, announces the delivery and installation of the Cyclone® 230 for a new proton therapy center in Dimitrovgrad (Ulyanovsky region, Russia). The center will be a part of the Federal High-Tech Center of Medical Radiology of the Federal Medico-Biological Agency of Russia (FMBA).

IBA will equip the centre with the Proteus®PLUS* four-treatment room configuration, which provides the best in class treatment with Image Guided Intensity Modulated Proton Therapy (IMPT).
 
The installation of the facility started in August 2016. The acceptance of the first treatment room is planned for the end of 2017. The proton therapy center in Dimitrovgrad will be IBA’s first in the Russian Federation and is expected to treat up to 1,200 patients per year.
 
The Head of FMBA, Mr. Vladimir Uiba, Governor of Ulaynovsky region, Mr. Sergey Morozov, and local media were in attendance at this important event for IBA, FMBA and Russia. Representing IBA was Vice-President and the Director of the IBA’s Representative office in Russia, CIS Mr. Kirill Makarenko, as well as the wider IBA site team. 
 
Mr. Vladimir Uiba, Head of FMBA of Russia, emphasized: ''This is a historical event not only for the Ulyanovsky region but also for the whole country. The proton therapy technology produced by IBA is ground-breaking and highly-praised also by the scientists and specialists in the Joint Institute of Nuclear Research in Dubna. Proton therapy is a unique method for cancer treatment and it is at the cutting edge of innovation in oncology.”
 
Kirill Makarenko, Vice-President of IBA and Director of the IBA’s Representative office in Russia, commented on this achievement and its importance for the Russian region: “There are around 500,000 new cancer cases diagnosed in Russia every year and many of them could be treated with proton therapy. The center in Dimitrovgrad will be the first of its kind available to cancer patients from the Ulyanovsky region and the whole Privolzhsky Federal District.”

* Proteus®PLUS is the brand name of a Proteus®235 configuration.

Video on the Russia TV Channel: https://www.youtube.com/watch?v=T0XrbeO8FuM

News

21/11/2017 News

RAYSEARCH ENTERS AGREEMENT WITH SUMITOMO FOR BORON NEUTRON CAPTURE THERAPY

RaySearch and Sumitomo Heavy Industries, Ltd. (Sumitomo), based in Tokyo, Japan, have entered into an agreement regarding treatment planning for boron neutron capture therapy (BNCT) – a unique type of radiatio [...]

07/11/2017 News

Raysearch enters into the field of Boron Neutron Capture Therapy

RaySearch and Neutron Therapeutics, Inc., based in Danvers, US, have entered into an agreement regarding treatment planning for boron neutron capture therapy (BNCT), which is a unique type of radiation therapy that en [...]

03/11/2017 Radioterapia

RayStation selected for CYCLHAD Hadrontherapy Center, France (Archade program)

Following a competitive tender process, RayStation has been chosen as the treatment planning system for the CYCLHAD Hadrontherapy Center, located in Caen, France. The center is due to open in 2018 and will be France&r [...]

Eventi

20gen2017 | Eventi

RayCare Symposium, Roma 26 gennaio 2017

Tecnologie Avanzate è lieta di comunicare che il 26 gennaio organizza a Roma il primo RayCare Symposium, un incontro destinato a presentare in [...]

26nov2017 | Eventi

XXI CONGRESSO NAZIONALE AINO - Trento, 26-29 novembre 2017

Tecnologie Avanzate sarà sponsor del "XXI CONGRESSO NAZIONALE AINO" Associazione Italiana di Neuro-Oncologia che avrà luogo a Trent [...]

Video gallery